
    
      The CP288 study is an investigation of a non-CE marked stoma product which was conducted in
      the UK, Italy, Netherlands, Germany, and Norway. The study enrolled 79 subjects. The study is
      a randomized, open-label, comparative study. The study is now complete.
    
  